Heather Hobbs NEWS&VIEWS Bringing you the latest Business News and updates from the Science Industry Millipore Expands CRO Services in Europe
Millipore Corporation has moved its European BioPharma Services unit to new, expanded facilities to accommodate strong growth in the biotechnology sector. The new facilities are located in Milton Park, near Didcot in Oxfordshire, England.
Millipore’s BioPharma Services unit is the first global contract research organisation (CRO) dedicated exclusively to large molecule bioanalytical work. The unit arose from Millipore’s acquisition in August, 2009 of BioAnaLab, an Oxford University spin-out, specialising in the analysis of biopharmaceuticals.
The medical faculty of the South Korean Yonsei University and Carl Zeiss celebrated the opening of an Advanced Imaging Centre on April 20. Equipped with Zeiss microscope systems for biomedical research, including the LSM 710 and LSM 700 laser scanning microscopes, the centre will stage international workshops aimed at presenting the latest methods in the field of imaging.
TO FIND OUT MORE CIRCLE NO.
Acquisition Opens up Cytogenetic Testing Arena For PerkinElmer
PerkinElmer has entered into a definitive agreement to acquire Signature Genomic Laboratories, LLC, (Spokane, Washington), which specialises in diagnostic cytogenetic testing of chromosome abnormalities in individuals with unexplained physical and developmental disabilities.
“We are delighted to have Signature become part of the PerkinElmer team. Signature brings very strong complementary assets for diagnosing disorders that are often undetected by traditional genetic tests,” said Robert Friel, Chairman and Chief Executive Officer of PerkinElmer. “Patients, families, researchers and clinicians will benefit from our combined expertise, as accurate diagnosis is crucial to providing answers that lead to better care, treatment and understanding of patients with birth defects, behavioural issues, delay in development or learning problems.”
Founded in 2003 by Lisa G. Shaffer, PhD and Bassem A. Bejjani, MD, Signature Signature’s microarray diagnostic technology is available for both pre-natal and post-natal identification of DNA alterations associated with genetic disease. More recently, Signature launched a suite of services for the diagnosis of patients with leukemia.
“As a global leader in genetic screening technologies and services, PerkinElmer clearly has the resources and worldwide presence to enable our combined testing services to reach more patients and families,” said Dr Shaffer, President and CEO, Signature. “We believe that this move will not only benefit patient populations around the world, but help us continue our success in genetic diagnostic innovation.”
TO FIND OUT MORE CIRCLE NO. 53 51 Dionex Honours IC Pioneer
Dionex Corporation has announced a permanent academic endowment at The University of Texas at Arlington that will benefit the Department of Chemistry and Biochemistry in College of Science. The endowment will set up The Hamish Small Chair of Ion Analysis to honour Hamish Small, the inventor of suppressed ion chromatography.
Employed as a purification technique starting late in the 19th century, the use of ion exchange as an analytical technique for inorganic chemicals was limited by the difficulty of detecting ions in a highly conductive background. Hamish Small developed an ionic suppressor that enabled direct detection of charged species with a conductivity detector. This eventually led to the establishment of Dionex Corporation, recognised as a market leader in IC instrumentation.
Hamish Small
“Hamish Small is one of the giants of modern analytical chemistry,” said Christopher Pohl, Senior Vice President of R&D and Chief Science Officer at Dionex Corporation. “His contributions to analytical chemistry are numerous, including: Indirect Photometric Detection, Hydrodynamic Chromatography, and Ion Chromatography. We at Dionex, wanted to honour his many contributions to analytical chemistry by permanently endowing a chair, named in his honour, and feel that the University of Texas at Arlington is a perfect setting for such an honour.”
It is the intent of Dionex Corporation to give a total of USD 500,000 to the endowment by 2014.
TO FIND OUT MORE CIRCLE NO. 54
Geoff Hale, Managing Director of BioAnaLab, said: “The new laboratory provides us with space to continue our growth as we expand the range of services we provide.” Craig Morley, Global Managing Director of Millipore’s BioPharma Services added: "The new facility complements the outstanding facilities at our St. Charles site and is a significant milestone in our development as ‘The World's Large Molecule Lab.’
TO FIND OUT MORE CIRCLE NO. 52
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204 |
Page 205 |
Page 206 |
Page 207 |
Page 208 |
Page 209 |
Page 210 |
Page 211 |
Page 212 |
Page 213 |
Page 214 |
Page 215 |
Page 216 |
Page 217 |
Page 218 |
Page 219 |
Page 220
